Gurdeep Parmar

494 citations
15 papers · 51 indexed · h-index 5
Topics
Multiple Myeloma Research and Treatments (12 papers)Peptidase Inhibition and Analysis (4 papers)Cancer Treatment and Pharmacology (3 papers)

In The Last Decade

Gurdeep Parmar

13 papers receiving 50 citations

Peers

Gurdeep Parmar
Comparison fields: 5 of 27
  • Oncology 23
  • Hematology 23
  • Emergency Medical Services 18
  • Molecular Biology 17
  • Pulmonary and Respiratory Medicine 12
Replace Fabrizio Ciambelli with:
Fabrizio Ciambelli Italy
Vladimir Otašević Serbia
Christoph Gold Germany
Charlotte Fenioux France
Nicola Jackson United Kingdom
Catherine Sperlich Canada
Aarash Saleh United Kingdom
Neal Sule United States
Petrucci
Hila Magen‐Nativ Israel
Gurdeep Parmar relative to Fabrizio Ciambelli Italy Fabrizio Ciambelli's profile →
Citations per field
00.5×3.3×
Fabrizio Ciambelli · 1×
Citations per year

Countries citing papers authored by Gurdeep Parmar

Since Specialization
Citations

This map shows the geographic impact of Gurdeep Parmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gurdeep Parmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gurdeep Parmar more than expected).

Fields of papers citing papers by Gurdeep Parmar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gurdeep Parmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gurdeep Parmar. The network helps show where Gurdeep Parmar may publish in the future.

Co-authorship network of co-authors of Gurdeep Parmar

This figure shows the co-authorship network connecting the top 25 collaborators of Gurdeep Parmar. A scholar is included among the top collaborators of Gurdeep Parmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gurdeep Parmar. Gurdeep Parmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 4
5 3
6 1
7 7
8 1
9 5
10 4
11 1
12 18
13 2
14 1
15 2

About Gurdeep Parmar

Gurdeep Parmar is a scholar working on Hematology, Oncology and Pharmaceutical Science, having authored 15 papers that have together received 51 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Internal Medicine (12 citations), Emergency Medical Services (18 citations) and Hematology (23 citations). Gurdeep Parmar has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Daniel Brungs, Hang Quach, Sumit Madan, Enrique M. Ocio, María‐Victoria Mateos, Nobuhiro Tsukada, Pierre Bories, Sandrine Macé, Kazutaka Sunami and Florence Suzan. Their work appears in journals such as Journal of Clinical Oncology, Blood and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026